October’s SLAS Technology Special Issue Published

“Engineering Innovations for Fundamental Biology and Translational Medicine” Now Accessible


For Immediate Release: October 10, 2019

Contact Information:

Jill Hronek, Director of Marketing Communications

Telephone: +1.630.256.7527, ext. 103

E-mail:  jhronek@slas.org

Newswise — October’s SLAS Technology Special Issue Focuses on the Hot Topic, “Engineering Innovations for Fundamental Biology and Translational Medicine”

Oak Brook, IL – In the October Special Issue of SLAS Technology, Guest Editors Soojung Claire Hur, Ph.D., and Deok-Ho Kim, Ph.D., (Johns Hopkins University; Baltimore, MD, USA) introduce a collection of articles and reviews focused on the advancement in technologies that are playing a major role in shifting healthcare closer to more predictive, preventative and personalized medicine.

Growing clinical evidence shows that prescribing patient treatments based on population average is no longer an effective healthcare strategy. Because of this, the movement towards personalized medicine has grown exponentially which necessitates a transformation for physicians to provide diagnostic tests and determine treatment protocol for the individual patient.

The following reviews and original research focus on how scientists and clinicians are integrating innovative technologies with existing clinical workflows to advance personal patient care:

  • Biomicrofluidic Systems for Hematologic Cancer Research and Clinical Applications
  • Advances in Technologies for Purification and Enrichment of Extracellular Vesicles
  • Quantification of In Vivo Target Engagement Using Microfluidic Activity-Based Protein Profiling
  • An Equipment-Free, Paper-Based Electrochemical Sensor for Visual Monitoring of Glucose Levels in Urine
  • Fabrication of Bioengineered Skin by Injection Molding: A Feasibility Study on Automation
  • Controlling Macroscopic Phase Separation of Aqueous Two-Phase Polymer Systems in Porous Media
  • Rapid Production and Recovery of Cell Spheroids by Automated Droplet Microfluidics
  • Framework Nucleic Acids: A Paradigm Shift in Transdermal Drug Delivery

Access to this SLAS Technology Special Issue is available at https://journals.sagepub.com/toc/jlad/24/5 through October 20. For more information about SLAS and its journals, visit www.slas.org/journals.

*****

SLAS (Society for Laboratory Automation and Screening) is an international community of 19,000 professionals and students dedicated to life sciences discovery and technology. The SLAS mission is to bring together researchers in academia, industry and government to advance life sciences discovery and technology via education, knowledge exchange and global community building.

SLAS Discovery: Advancing Life Sciences R&D, 2018 Impact Factor 2.192. Editor-in-Chief Robert M. Campbell, Ph.D., Eli Lilly and Company, Indianapolis, IN (USA).

SLAS Technology: Translating Life Sciences Innovation, 2018 Impact Factor 2.048. Editor-in-Chief Edward Kai-Hua Chow, Ph.D., National University of Singapore (Singapore).  

 

SEE ORIGINAL STUDY


Comment/Share

Chat now!
7.19413